Paid Clinical Trials in Bel Air, MD
As of June 2026, 33 paid clinical trials are recruiting in Bel Air, Maryland. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Bel Air offers studies at sites including UM Upper Chesapeake Medical Center for conditions such as Breast Cancer, Anatomic Stage II Breast Cancer AJCC v8, Metastatic Malignant Neoplasm in the Brain, Anatomic Stage I Breast Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Bel Air
Trials by drug in Bel Air
Filter results
33 clinical trials
↓ Download CSVUMMS Sepsis Early Prediction Score (SEPSys) and RESCUE Score Combined Clinical Trial
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
E-Mindfulness Approaches for Living After Breast Cancer
A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
ALTO-100 in Bipolar Disorder With Depression (BD-D)
Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Testing the Pain Clinical Practice Guideline
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
TERPS Trial for de Novo Oligometastic Prostate Cancer
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Prospective Case Collection Study for New Mammography Technologies
GammaPod Dose Escalation Radiation for Early Stage Breast Cancer
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
LITT Followed by Hypofractionated RT for Recurrent Gliomas
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
GammaPod Registry and Quality of Life Nomogram
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
About research studies in Bel Air
Bel Air has approximately 33 recruiting research studies across a wide range of therapeutic areas. Maryland hosts Johns Hopkins Medicine and the NIH Clinical Center in Bethesda, giving participants access to some of the most advanced early-phase research in the country.
Top Research Study Locations in Bel Air
Researchers run research studies in Bel Air, MD at 11 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| UM Upper Chesapeake Medical Center | Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer, Metastatic Malignant Neoplasm in the Brain | 19 |
| Upper Chesapeake Health | Breast Cancer, Breast Cancer Female, Cervical Cancer | 5 |
| MedStar Health Bel Air Medical Campus | Breast Cancer, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 4 |
| UCH Kaufman Cancer Center | Brain Tumor, Glioblastoma, Glioma | 2 |
| Clearway Pain Solutions - Bel Air | Lumbar Spinal Stenosis | 1 |
| Local Institution - 0017 | Schizophrenia | 1 |
| Lorein Bel Aire | Dementia, Pain | 1 |
| National Spine and Pain Centers | Lumbar Spinal Stenosis | 1 |
| Progressive Radiology | Mammography | 1 |
| University of Maryland Upper Chesapeake Medical Center | Patient Deterioration, Sepsis | 1 |
| Upper Chesapeake- Kaufman Cancer Center | Non-Small Cell Lung Cancer | 1 |
Active & Upcoming Studies in Bel Air (2026)
Recruiting trials in Bel Air grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (27 active studies)
- GCCC 2578 Randomized Photon vs Proton RT for Newly Diagnosed Gynecologic Primaries · Phase 2 · University of Maryland, Baltimore
- ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab · Phase 3 · Alliance for Clinical Trials in Oncology
Mental health & behavior (3 active studies)
- Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU) · Bristol-Myers Squibb
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Neurology & pain (1 active study)
- Testing the Pain Clinical Practice Guideline · Phase 2 · University of Maryland, Baltimore
Common conditions studied in Bel Air
- Breast Cancer (4 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Metastatic Malignant Neoplasm in the Brain (3 active studies). Recruiting Metastatic Malignant Neoplasm in the Brain studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Anatomic Stage I Breast Cancer AJCC v8 (2 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Brain Tumor (2 active studies). Recruiting Brain Tumor studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Glioblastoma (2 active studies). Glioblastoma studies investigate tumor-treating fields, targeted small molecules, and immunotherapy combinations for this aggressive brain cancer.
Leading research sponsors in Bel Air
- University of Maryland, Baltimore
- NRG Oncology
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
Local regulations and guidelines
Clinical trials in Maryland are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Maryland research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Bel Air. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Bel Air
Hipa.ai aggregates every recruiting study in Bel Air from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Bel Air?
There are approximately 33 recruiting clinical trials in Bel Air, Maryland listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Bel Air pay participants?
Most recruiting trials in Bel Air compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Bel Air?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Bel Air?
The most common conditions under active study in Bel Air include Breast Cancer (4), Anatomic Stage II Breast Cancer AJCC v8 (3), Metastatic Malignant Neoplasm in the Brain (3), Anatomic Stage I Breast Cancer AJCC v8 (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Bel Air?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Bel Air on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Bel Air?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Bel Air?
Recruiting research sites in Bel Air include UM Upper Chesapeake Medical Center, Upper Chesapeake Health, MedStar Health Bel Air Medical Campus, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Bel Air right now?
The largest active categories in Bel Air are Cancer & tumors (27), Mental health & behavior (3), Neurology & pain (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.